Goldman Sachs raised the firm’s price target on Intuitive Surgical (ISRG) to $714 from $621 and keeps a Buy rating on the shares. After a year when fundamentals diverged from stock performance, 2026 should represent a return to normalized patterns where organic growth defines relative valuation, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $616 from $589 at BTIG
- U.S. Chess Champion is Bullish on These Two New Stocks – ASTS and SNDK
- Intuitive Surgical price target raised to $686 from $635 at Barclays
- Intuitive Surgical price target raised to $580 from $540 at Evercore ISI
- U.S. Chess Champion Is Bullish on these 3 Stocks